ICPD: “Sleep Attacks” May Occur In Parkinson’s Patients Taking Dopaminergic Agents
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




ICPD: “Sleep Attacks” May Occur In Parkinson’s Patients Taking Dopaminergic Agents

By Richard Robinson
Special to DG News

HELSINKI, FINLAND -- July 31, 2001 -- Sudden, irresistible onset of sleep-known as "sleep attacks"-can occur in Parkinson's patients who are being treated with any of the dopamine agonists or levodopa.

These attacks, which have led to automobile accidents and several deaths in patients with Parkinson's disease (PD), have been the source of much controversy since their first description in 1999, according to Nik Homann, MD.

Dr. Homann, from Karl Franzens University in Graz, Austria, performed a meta-analysis of all published sleep attack reports. He presented the results of his study, titled, "Sleep events with dopamine agonists: Fact and fiction", today (July 31) at the 14th International Congress on Parkinson’s Disease in Helsinki, Finland.

Sleep attacks were first described in eight patients on the newest dopamine agonists-ropinirole and pramipexole-and immediately led both to more reports and to disputes about their existence in patients who were not already excessively sleepy.

However, Dr. Homann reported that several investigators, including himself, have witnessed the onset of these attacks personally. In his case, he witnessed two patients whose sleep onset was half an hour after a single dose of apomorphine, who showed rapid and profound sleep onset, followed by unresponsiveness to pain or movement, and retrograde amnesia upon awakening.

"This [type of sleep onset] is not the same as the gradual onset of sleep in over-tired patients," Dr. Homann said.

His meta-analysis showed that sleep attacks have been reported in 123 patients. There were more men than women, and patients ranged from ages 34 to 87 years, with onset as early as one year after diagnosis.

All dopamine agonists were implicated in these attacks, as well as levodopa, he said. While the attacks were more common with the newer agonists, Dr. Homann noted this was more likely to be due to the higher prescription rate for these drugs than any special properties they might possess.

While dose reduction can mitigate the frequency of sleep attacks, Dr. Homann said this is often impractical, since this can lead to motor disability.

"We're still looking for something to offer these patients," he said, but suggested modafinil may be useful in some patients.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities